Bunhill: Anyone for tennis?
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.I THOUGHT readers might like to be reminded of the prodigious talents of Jan Leschly, the chief exeutive of SmithKline Beecham. Last week, Leschly paid dollars 2.9bn to acquire Sterling Health. The deal has rocketed SmithKline right to the top of the pharmaceuticals sector.
As my picture shows, before embarking on a business career, the 52-year-old had a successful time of it on the tennis court. However, although primarily known as a tennis player, he is almost certainly a better businessman.
You see, he never quite made it to the top in tennis - he was once ranked 10th in the world. But he is now ranked number one at SmithKline.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments